Griffiths W J, Kelly A L, Smith S J, Cox T M
Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
QJM. 2000 Sep;93(9):575-87. doi: 10.1093/qjmed/93.9.575.
The recent discovery of HFE, the MHC-Class-I-like gene mutated in up to 90% of patients with hereditary haemochromatosis, and the gene encoding the Nramp2/divalent metal transporter-1 (DMT-1) implicated in ferrous iron transport holds promise for a greater understanding of human iron metabolism. Since the HFE protein can be crystallized as a ternary complex with the transferrin receptor and iron-saturated transferrin, and DMT-1 expression is up-regulated in hereditary haemochromatosis, these proteins are likely to interact in a common pathway for human iron homeostasis. To investigate the cellular interactions between the cognate proteins encoded by these genes, we generated a panel of rabbit and avian antisera from human HFE and DMT-1 derived peptides. The antibodies were characterized by ELISA reactions and Western immunoblotting. Immunohistochemical staining showed that DMT-1 protein localized to the brush border of human duodenum where it is predicted to serve as the principal transporter of ferrous iron from the intestinal lumen. In the human cell lines, Caco-2 (small intestinal phenotype upon differentiation) and K562 (erythroleukaemic) HFE, in the presence of iron-saturated transferrin, co-localized with transferrin receptors in an early endosome compartment using confocal immunofluorescence microscopy. This interaction may be critical in small-intestinal crypt cells which express HFE, where it may function to modulate their intrinsic iron status thereby programming iron absorption by DMT-1 in the mature enterocyte. In undifferentiated Caco-2 cells, DMT-1 localized to a discrete late endosome compartment distinct from that occupied by HFE where, in addition to brush-border iron uptake, it may function to regulate the availability of iron delivery to intracellular iron pools. Disruption of the HFE gene as a result of mutations associated with hereditary haemochromatosis may thus impair homeostatic mechanisms controlling iron absorption within the small-intestine epithelium by a direct interaction with transferrin receptors and by subsequent alteration of DMT-1 expression. Identification of the molecular interactions of HFE with DMT-1 and other key components of the iron transport pathway has implications for a mechanistic understanding of the pathophysiology of human iron storage diseases as well as the regulation of normal iron balance.
最近发现的HFE基因是一种与MHC-I类相似的基因,在高达90%的遗传性血色素沉着症患者中发生突变,而编码Nramp2/二价金属转运蛋白-1(DMT-1)的基因与亚铁转运有关,这为更深入了解人类铁代谢带来了希望。由于HFE蛋白可以与转铁蛋白受体和铁饱和转铁蛋白形成三元复合物结晶,并且DMT-1在遗传性血色素沉着症中表达上调,这些蛋白可能在人类铁稳态的共同途径中相互作用。为了研究这些基因编码的同源蛋白之间的细胞相互作用,我们从人HFE和DMT-1衍生肽中制备了一组兔和禽抗血清。通过ELISA反应和Western免疫印迹对抗体进行了表征。免疫组织化学染色显示,DMT-1蛋白定位于人十二指肠的刷状缘,预计它在那里作为亚铁从肠腔进入的主要转运蛋白。在人细胞系Caco-2(分化后呈小肠表型)和K562(红白血病)中,在铁饱和转铁蛋白存在的情况下,使用共聚焦免疫荧光显微镜观察到HFE与转铁蛋白受体在早期内体区室中共定位。这种相互作用在表达HFE的小肠隐窝细胞中可能至关重要,在那里它可能起到调节细胞内铁状态的作用,从而调控成熟肠细胞中DMT-1介导的铁吸收。在未分化的Caco-2细胞中,DMT-1定位于一个与HFE所在区域不同的离散晚期内体区室,在那里,除了刷状缘铁摄取外,它可能还起到调节向细胞内铁池输送铁的可用性的作用。与遗传性血色素沉着症相关的突变导致的HFE基因破坏,可能通过与转铁蛋白受体的直接相互作用以及随后DMT-1表达的改变,损害控制小肠上皮内铁吸收的稳态机制。确定HFE与DMT-1以及铁转运途径其他关键成分的分子相互作用,对于从机制上理解人类铁储存疾病的病理生理学以及正常铁平衡的调节具有重要意义。
Proc Natl Acad Sci U S A. 1999-2-16
Blood. 2000-12-15
Blood Cells Mol Dis. 2002
J Clin Invest. 2000-5
Food Sci Nutr. 2020-9-13
Environ Sci Pollut Res Int. 2018-11-1
Curr Top Membr. 2012
Neuromolecular Med. 2009-11-10